Perceptive Advisors LLC Albireo Pharma, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $10.9 Million - $14.3 Million	-602,979 Reduced 25.55%	1,757,160 $38 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $9.28 Million - $16.6 Million	400,000 Added 20.41%	2,360,139 $78.8 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $2.99 Million - $6.97 Million	255,809 Added 15.01%	1,960,139 $31.9 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $10.3 Million - $15.1 Million	384,330 Added 29.12%	1,704,330 $55.5 Million
Q4 2017 Feb 14, 2018	BUY	$21.56 - $28.14 $10.2 Million - $13.4 Million	475,000 Added 56.21%	1,320,000 $33.8 Million
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $17.3 Million - $21.7 Million	845,000	845,000 $17.7 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.